πŸ‡ΊπŸ‡Έ FDA
Patent

US 6764998

6,11-4C-bicyclic 9a-azalide derivatives

expired A61PA61P31/04

Quick answer

US patent 6764998 (6,11-4C-bicyclic 9a-azalide derivatives) held by Enanta Pharmaceuticals, Inc. expires Mon Jul 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Jul 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P31/04